Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Porcine PRRS vaccine is a veterinary vaccine candidate under development by Spirit Jinyu Biological Pharmaceutical (Jinyu Biotechnology) for the prevention of Porcine Reproductive and Respiratory Syndrome (PRRS) in swine. PRRS, often referred to as "blue-ear pig disease," is caused by the Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) and is characterized by reproductive failure in sows and severe respiratory distress in piglets and growing pigs. This vaccine is designed to stimulate the porcine immune system to recognize PRRSV antigens, thereby inducing protective humoral and cellular immunity to reduce clinical disease and viral shedding. As of recent pipeline reports, the vaccine is in the laboratory research or preclinical stage of development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Porcine PRRS vaccine (Spirit Jinyu).